Earnings Quality

Earnings Quality

EPAM's headline free cash flow is large: $613 million in 2025, more than 1.6 times reported net income, a yield near 13.5% on the equity. Most of that ratio is an artifact. The 2024 acquisitions tripled a non-cash amortization charge that depresses reported earnings, and $177 million of stock compensation is added back to cash. Measured against the earnings management actually guides on, free cash flow converts at about 95%, not 150%. The cash is clean; the owner's yield is nearer 10%.

Two earnings numbers that disagree by 71%

For 2025 EPAM reported GAAP diluted earnings of $6.72 per share and non-GAAP diluted earnings of $11.50 — a gap of $4.78, or 71% [1]. The same split runs through the income statement: GAAP income from operations was $520 million (a 9.5% margin, down 4.5% on the year), while non-GAAP income from operations was $831 million, a 15.2% margin that management reports as up 6.7% [2]. One set of numbers says the business shrank; the other says it grew. The $311 million between them is the subject of this chapter.

Source: Q4/FY2025 earnings call, full-year 2025 results [3].

What the conversion ratio is really measuring

The report's opening chapter noted free cash flow converting at more than 150% of net income and a free-cash-flow yield around 13.5% (The De-Rating). Both figures are correct on their face, and both are flattered by the same thing: a GAAP net income denominator that has been pushed down by non-cash charges.

The bridge from GAAP to non-GAAP operating income is dominated by two items. Stock-based compensation was $176.8 million in 2025, split $86.3 million into cost of revenue and $90.5 million into SG&A [2]. Amortization of purchased intangibles was $71.4 million — up from $29.5 million in 2024 [4] and $22.7 million in 2023 [5]. That threefold jump is not operational; it is the accounting tail of the $927 million NEORIS and First Derivative deals closed in late 2024, whose purchase price created $384 million of intangible assets now being written off against earnings (Capital and Alignment).

Sources: net income and free cash flow from the FY2025 Consolidated Statements of Cash Flows [6]; non-GAAP net income (~$645M) derived from the 94.7% adjusted-conversion figure management reported [7].

The 162% figure divides $613 million of free cash flow by $378 million of GAAP net income [8]. But the same amortization and stock compensation that suppress GAAP net income are added straight back inside operating cash flow, so they inflate the ratio at both ends. Management frames the conversion differently, and more honestly: $613 million of free cash flow is "a 94.7% adjusted net income conversion" — that is, roughly 95% of the ~$645 million of non-GAAP net income the company guides on [9]. A company converting adjusted earnings to cash at 95% is doing well, but the 1.6x figure the GAAP ratio implies overstates the conversion.

What is fair to exclude, and what is not

Not all of the $311 million adjustment is created equal. Two pieces genuinely belong outside a picture of cash economics: the $71.4 million of purchased-intangible amortization is a non-cash write-down of acquisition accounting, and the year's $25.9 million foreign-exchange loss reflects currency translation rather than operations [10]. Strip those out and the 9.5% GAAP operating margin does understate the underlying business.

The largest single piece does not belong outside the picture. Stock-based compensation of $176.8 million — 3.2% of revenue — is a real, recurring cost of paying a workforce of roughly 60,000 partly in equity [2]. It is non-cash to the company only because the cost is borne by shareholders through dilution instead. It appears twice in the bull case — once lifting non-GAAP EPS to $11.50, and again as an add-back inside the $613 million of free cash flow — and both times it makes the return look larger than an owner receives. EPAM buys back stock to offset that dilution, but at prices well above today's, so the offset has cost more than the dilution it neutralised (Capital and Alignment).

Sources: stock-based compensation totals for all three years from Note 15 [2]; purchased-intangible amortization from the FY2025 segment reconciliation [11], [12]; 2026 figures are management's guidance assumptions [13].

Charging stock compensation in full against free cash flow reframes the yield. On $613 million and roughly $4.5 billion of equity value, the headline yield is about 13.5%. Subtract the $177 million of stock compensation and free cash flow to owners is closer to $436 million, a yield near 9.6%. At $86 EPAM is priced below the value of its own cash flow standing still — owner free cash flow of ~$436m (reported FCF less a full $176.8m stock-comp charge) capitalised flat at 10% is worth ~$107 a share — so the price embeds a permanent ~3%/yr decline in owner cash flow even though FY2025 organic revenue still grew 4.9% in constant currency and management guides FY2026 organic growth to 3-6% (What the Price Implies).

Source: derived from FY2025 free cash flow and stock-based compensation [14], [2]; equity value per The De-Rating.

The parts that are genuinely clean

Where the accounting is not doing the work, EPAM's cash generation is high quality by the ordinary tests. Capital spending was $42.2 million in 2025 — under 0.8% of revenue — so operating cash flow of $655 million dropped almost intact to $613 million of free cash flow, with no reinvestment or hidden capex draining it [15]. The asset-light model the report opened with is real in the cash statement, not just the narrative.

Collections are equally undramatic. Trade receivables and contract assets rose 10.6% to $1.11 billion while revenue grew 15.4%, so days sales outstanding actually eased — management reported 72 days at year-end versus 70 a year earlier and 75 in the prior quarter [16], [17]. There is no channel-stuffing tell here: cash is being collected, not booked and awaited. Cash interest paid was $1.4 million, consistent with the debt-free balance sheet [18]. The quality question here is one of framing, not integrity.

Two caveats before crediting the run-rate

The $144 million swing in accrued liabilities flattered 2025 operating cash flow; accrued compensation and benefits alone rose $123 million on stronger second-half variable pay [19], [20]. Strip it out and normalized operating cash flow sits closer to $510 million — still comfortably above capital spending, but short of the reported figure.

The second caveat runs against the "GAAP understates everything" defence. Margins compressed even on the adjusted numbers management prefers: non-GAAP operating margin fell from about 16.5% in 2024 to 15.2% in 2025, so the earnings decline is not purely an amortization illusion — real mix and cost pressure sit underneath it, from higher variable compensation to the introduction of lower-utilization junior staff [21].

Sources: GAAP operating margin from the FY2025 MD&A results of operations [22]; non-GAAP operating margin from the Q4/FY2025 earnings call, with FY2024 derived from the 6.7% growth management reported [23].

The read

EPAM's free cash flow is real, cleanly collected, and barely touched by capital spending — but it is not the 150%-of-earnings gusher the GAAP ratio suggests. The right way to read it sits between the two numbers the company publishes. Purchased-intangible amortization and foreign-exchange losses genuinely depress GAAP earnings without touching cash, so the 9.5% reported operating margin understates the business. Stock compensation, the largest adjustment, does not: charge it in full and free cash flow converts at roughly 95% of adjusted earnings and yields near 10% rather than 13.5%. For the margin-of-safety question the report is built around, that still leaves an attractive cash return on a net-cash balance sheet, thinner than the headline and most sensitive to stock compensation.

The near-term direction of that cost is the wrong way: management guides 2026 stock compensation up to about $202 million even as intangible amortization eases to $69 million [24]. The read would firm up if stock compensation flattened as a share of revenue and the accrued-liability tailwind normalised while free cash flow held; it would weaken if the equity bill keeps climbing against slower revenue, because then the owner's yield erodes even as the reported one looks steady. The counter-case is fair: EPAM repurchases enough stock to shrink the share count, so a portion of the compensation cost is being funded rather than left to dilute — though, as the capital chapter showed, at prices that made the funding expensive.